Helius Medical Technologies, Inc. (HSDT)
HSDT Stock Price Chart
Explore Helius Medical Technologies, Inc. interactive price chart. Choose custom timeframes to analyze HSDT price movements and trends.
HSDT Company Profile
Discover essential business fundamentals and corporate details for Helius Medical Technologies, Inc. (HSDT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
27 Jun 2014
Employees
21.00
Website
https://heliusmedical.comCEO
Dane Carl Andreeff
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
HSDT Financial Timeline
Browse a chronological timeline of Helius Medical Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$79.73 surpassing the estimated -$128.50 by +37.95%, while revenue for the quarter reached $43.00K , missing expectations by -60.91%.
Stock split effective on 1 Jul 2025
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 2 May 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 May 2025
EPS came in at -$382.31 falling short of the estimated -$8.70 by -4.29K%, while revenue for the quarter reached $49.00K , missing expectations by -55.45%.
Earnings released on 25 Mar 2025
EPS came in at -$1.03 falling short of the estimated -$0.94 by -9.57%, while revenue for the quarter reached $152.00K , beating expectations by +52.00%.
Earnings released on 12 Nov 2024
EPS came in at -$0.99 surpassing the estimated -$1.06 by +6.60%, while revenue for the quarter reached $51.00K , missing expectations by -49.00%.
Earnings released on 12 Aug 2024
EPS came in at -$0.64 falling short of the estimated -$0.50 by -28.00%, while revenue for the quarter reached $182.00K , beating expectations by +21.33%.
Earnings released on 13 May 2024
EPS came in at -$3.08 surpassing the estimated -$3.87 by +20.41%, while revenue for the quarter reached $135.00K , beating expectations by +3.85%.
Earnings released on 28 Mar 2024
EPS came in at -$1.47 surpassing the estimated -$4.05 by +63.70%, while revenue for the quarter reached $134.00K , missing expectations by -46.40%.
Earnings released on 9 Nov 2023
EPS came in at -$5.49 surpassing the estimated -$6.00 by +8.50%, while revenue for the quarter reached $143.00K , missing expectations by -48.93%.
Stock split effective on 17 Aug 2023
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Aug 2023
EPS came in at -$3.00 surpassing the estimated -$5.50 by +45.45%, while revenue for the quarter reached $256.00K , missing expectations by -20.00%.
Earnings released on 11 May 2023
EPS came in at -$4.50 surpassing the estimated -$5.00 by +10.00%, while revenue for the quarter reached $111.00K , missing expectations by -72.25%.
Earnings released on 9 Mar 2023
EPS came in at -$8.50 falling short of the estimated -$5.50 by -54.55%, while revenue for the quarter reached $282.00K , beating expectations by +8.46%.
Earnings released on 14 Nov 2022
EPS came in at -$6.00 surpassing the estimated -$12.00 by +50.00%, while revenue for the quarter reached $196.00K , beating expectations by +17.01%.
Earnings released on 15 Aug 2022
EPS came in at -$48.50 falling short of the estimated -$1.12 by -4.23K%, while revenue for the quarter reached $119.00K , missing expectations by -66.94%.
Earnings released on 12 May 2022
EPS came in at -$57.50 falling short of the estimated -$1.13 by -4.99K%, while revenue for the quarter reached $190.00K , beating expectations by +18.75%.
Earnings released on 14 Mar 2022
EPS came in at -$65.50 falling short of the estimated -$1.16 by -5.55K%, while revenue for the quarter reached $258.00K , beating expectations by +158.00%.
Earnings released on 10 Nov 2021
EPS came in at -$100.50 falling short of the estimated -$87.50 by -14.86%, while revenue for the quarter reached $109.00K , beating expectations by +17.45%.
Earnings released on 12 Aug 2021
EPS came in at -$129.00 falling short of the estimated -$76.50 by -68.63%, while revenue for the quarter reached $71.00K , beating expectations by +28.79%.
Earnings released on 17 May 2021
EPS came in at -$82.50 falling short of the estimated -$61.00 by -35.25%, while revenue for the quarter reached $84.00K .
Earnings released on 10 Mar 2021
EPS came in at -$88.50 , while revenue for the quarter reached $191.00K .
Stock split effective on 4 Jan 2021
Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Nov 2020
EPS came in at -$139.86 falling short of the estimated -$3.15 by -4.34K%, while revenue for the quarter reached $131.00K .
HSDT Stock Performance
Access detailed HSDT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.